Article
Pharma In Brief - Federal Court Grants One Of Three Prohibition Applications For VIGAMOX® Eye Drops Containing Moxifloxacin Hydrochloride
This latest decision from the Federal Court is consistent with a recent trend towards a more literal construction of patent claims.
Norton Rose Fulbright Canada LLP
